Can I produce eggs?
AMH, AFC, cycle history and previous stimulation response help the specialist estimate ovarian response. This is mainly a quantity conversation.
FERT-019 · INTERNATIONAL PATIENT JOURNEY
IVF for Women Over 40 in Thailand
IVF after 40 is not one treatment with one success rate. It is a sequence of decisions about ovarian reserve, egg quality, embryo development, time, laboratory strategy, pregnancy health and how much uncertainty you are prepared to carry through another cycle.
Thailand can offer sophisticated fertility treatment and experienced reproductive-medicine teams, but the useful question is not simply “Can I have IVF after 40?” It is: what does my evidence suggest, what is the clinic proposing, and what would make us change direction?
AGE CHANGES THE QUESTIONS — NOT YOUR RIGHT TO CLEAR ANSWERSWHAT CHANGES AFTER 40?
Separate egg quantity from egg quality
Two ideas are often bundled together. Ovarian reserve helps estimate how many eggs the ovaries may recruit during stimulation. Egg quality is strongly influenced by age and affects fertilisation, embryo development and chromosomal normality. A reassuring AMH result does not make age irrelevant; a low AMH result does not tell you that pregnancy is impossible.
This distinction matters when comparing IVF clinics in Thailand. Ask the specialist to explain what your tests predict about response, then separately explain how age changes the probability of producing a transferable embryo and ultimately a live birth.
Useful consultation question: “Based on my age, AMH, AFC and previous cycles, what do you expect at each stage from follicles to mature eggs to blastocysts?”
01RecruitmentHow many follicles may respond?
02MaturityHow many retrieved eggs may be mature?
03FertilisationWhat happens after IVF or ICSI?
04BlastocystHow many embryos may reach this stage?
05TransferWhat is the realistic route to live birth?
THREE DIFFERENT QUESTIONS01 02 03
Do not let one headline “success rate” answer all three
Can I produce a usable embryo?
Age, egg competence, sperm factors and laboratory performance influence fertilisation and embryo development. This is where attrition becomes crucial.
Can treatment lead to live birth?
Embryo quality is only part of the picture. Transfer, uterine factors, miscarriage risk, general health and pregnancy risks also matter.
READ THE WHOLE FUNNEL
The number that matters is rarely the number you start with
An IVF cycle can begin with several follicles and end with fewer mature eggs, fewer normally fertilised eggs and fewer blastocysts. For women over 40, the chance that an embryo is chromosomally abnormal also rises with age. That is why a clinic should discuss attrition rather than simply celebrate the number of follicles on the first scan.
Ask for age-stratified outcomes and insist on definitions. Pregnancy per embryo transfer is not the same as live birth per cycle started. A clinic that transfers only selected embryos can show an impressive transfer statistic while saying little about how many patients reached transfer.
Cycle startedRetrievalMature eggsBlastocystsTransferLive birth
JLIT DECISION CHECKPOINT
Compare a treatment plan, not a marketing percentage.
JLIT can help you compare relevant fertility providers, named specialists, treatment pathways and current pricing in Thailand. For an over-40 patient, the comparison should include how each team interprets your reserve, previous cycles, embryo strategy and international travel window.
That gives you something practical to compare: who is treating you, what they propose, what the quotation includes, what could change the plan and what happens if the first cycle does not produce a transferable embryo.
Ask JLIT to organise
Provider and specialist options
Current treatment pricing
What the package includes
Likely treatment calendar
Travel and accommodation planning
Five stages before you book a flight
Collect records
Previous stimulation sheets, egg numbers, maturity, fertilisation, blastocyst grading, transfer history and pregnancy outcomes.
Update testing
Confirm which blood tests, ultrasound and semen investigations the Thai specialist needs before proposing treatment.
Define prognosis
Ask what the evidence suggests for your age and individual history, including the chance of cancellation or no transferable embryo.
Choose strategy
Own eggs, embryo banking, PGT discussion, fresh or frozen transfer and what would trigger a change of plan.
Price the journey
Medication, monitoring, retrieval, laboratory work, freezing, testing, transfer and travel—not just the advertised base cycle.
OVARIAN RESERVE
AMH and AFC are useful—but they do not turn back the biological clock
AMH and antral follicle count are often used to estimate how the ovaries may respond to stimulation. They can help a specialist choose a starting protocol and discuss whether a low, normal or high response is expected. They are not direct tests of egg quality and should not be sold as a personal pregnancy percentage.
AMHBlood marker associated with ovarian reserve.
AFCUltrasound count of recruitable follicles.
AgeMajor influence on egg competence and aneuploidy.
HistoryPrevious IVF response can be highly informative.
PGT-A AFTER 40
Genetic testing can provide information. It cannot manufacture a normal embryo.
PGT-A screens biopsied embryo cells for chromosome copy-number abnormalities. In an older age group, that information may influence which embryo is considered for transfer, but it does not improve the underlying quality of an egg or guarantee implantation, pregnancy or live birth.
The practical question is whether your expected number of blastocysts makes testing useful in your case. Ask what happens if there is only one embryo, how mosaic results are handled, what the laboratory's biopsy and vitrification pathway involves, whether genetic counselling is available and what each stage costs.
PGT-A CANadd chromosome-screening information
PGT-A CANNOTreverse age-related egg biology
ASKhow the result changes your decision
THE LABORATORY MATTERS
Your specialist plans the cycle. The embryology laboratory carries the embryos through it.
For IVF over 40, where each mature egg and each developing embryo can feel especially valuable, laboratory questions deserve more than a line in the brochure.
Why is conventional IVF or ICSI being proposed in your case?
What is the clinic's approach when embryos develop slowly or unevenly?
If PGT is planned, who performs biopsy and where is genetic analysis completed?
What embryo information will you receive, and when?
THE SAME AGE DOES NOT MEAN THE SAME PLANA B C D
Four over-40 scenarios that require different conversations
Good reserve, first IVF
A reasonable follicle count can improve the opportunity to retrieve eggs, but it does not erase age-related embryo attrition. Ask for realistic stage-by-stage expectations rather than reassurance based only on AMH.
Low reserve
The conversation may focus on expected egg yield, cancellation thresholds, whether repeated retrievals are sensible and how quickly decisions should be made if the first response is poor.
Previous IVF failure
Separate poor response, low maturity, fertilisation problems, embryo arrest, failed implantation and miscarriage. Changing medication does not solve every bottleneck.
Embryos already frozen
The discussion shifts toward embryo information, transfer preparation, uterine factors, genetic-test status where relevant and pregnancy health rather than another retrieval automatically.
IVF COSTS AFTER 40
Budget for the pathway you may actually need
Older patients may encounter additional testing, higher medication use, embryo freezing, PGT, more than one retrieval or a later frozen embryo transfer. None of those should be assumed, but they should be visible in the quotation before you commit.
BASEConsultation + stimulation + monitoring
+LABRetrieval + IVF/ICSI + culture
+OPTIONSFreezing + PGT where chosen
+NEXTTransfer + medication + follow-up
JLIT comparison rule: compare like with like. A low headline price is not useful if medication, anaesthesia, ICSI, blastocyst culture, freezing, storage or transfer are excluded.
PREGNANCY HEALTH AFTER 40
Getting an embryo to transfer is not the end of the medical conversation
Pregnancy at older maternal ages is associated with higher rates of several obstetric complications. Before treatment, your fertility specialist may recommend medical review based on your health, medications and history. This becomes particularly important for international patients who will return home for antenatal care.
Ask what pre-treatment assessment is required, whether any condition needs optimisation first and what information your obstetric team at home should receive after a positive pregnancy test. If you have hypertension, diabetes, cardiovascular disease or another significant condition, fertility treatment should fit into a broader medical plan rather than operate in isolation.
BEFORE IVFmedical fitness and medication review
AFTER TESTearly pregnancy follow-up
AT HOMEstructured obstetric handover
StimulationMedicines, doses, days, scans and hormone results
RetrievalFollicles, eggs retrieved and mature eggs
LaboratoryFertilisation method, fertilisation and embryo development
EmbryosGrades, day reached, freezing and PGT results if performed
TransferEmbryo transferred, endometrium and luteal support
OutcomePregnancy test, ultrasound, miscarriage or live birth information
TIME IS PART OF THE STRATEGY
Do not spend six months collecting opinions that do not change the decision
For a woman over 40, time can be clinically meaningful. That does not mean rushing into the first clinic or buying every add-on. It means making the diagnostic and comparison process efficient: collect records, obtain the tests that genuinely change management, ask each specialist the same core questions and decide what evidence would make you proceed, pause or change direction.
If embryo banking over more than one retrieval is proposed, ask what target the clinic is trying to reach and when the plan will be reviewed. If another cycle is suggested after a poor result, ask what will be different and why. A strategy should have decision points, not simply momentum.
READ SUCCESS RATES PROPERLY
A percentage without a denominator can send you in the wrong direction
Success-rate claims are especially difficult to interpret after 40 because patient selection changes the number dramatically. One clinic may quote clinical pregnancy after transfer; another may report live birth per retrieval; another may exclude cancelled cycles or focus on genetically tested embryos. Those figures cannot be compared as though they describe the same event.
PER CYCLE STARTEDIncludes patients who begin stimulation, including those who may never reach retrieval or transfer.
PER RETRIEVALStarts the denominator after egg collection, so cancelled stimulation cycles may disappear.
PER TRANSFERLooks only at patients who reached embryo transfer and can therefore appear substantially stronger.
LIVE BIRTHThe outcome most patients ultimately care about; it is not interchangeable with a positive test or clinical pregnancy.
Ask the clinic to show results for women close to your age and, where possible, distinguish own-egg cycles from donor-egg cycles and tested from untested embryo transfers. Then ask how many cycles were cancelled and how many patients had no embryo available for transfer. This is not an attempt to make statistics pessimistic; it is how you make them useful.
Also remember that clinic outcomes reflect who the clinic treats. A service accepting difficult cases can appear weaker than one that selects patients with a better prognosis. The fairest comparison combines published numbers with your specialist's explanation of your individual evidence.
ONE CYCLE · MANY DECISION POINTS
WHEN A CYCLE DOES NOT REACH TRANSFER
“No embryo to transfer” is an outcome that deserves an explanation
After 40, some IVF cycles end before transfer because response is poor, no mature eggs are obtained, fertilisation does not occur, embryos stop developing or no embryo is considered suitable for transfer. Those outcomes are painful, but each carries different information for the next decision.
If a cycle produces few follicles, the next conversation may concern ovarian response and whether a different stimulation approach is reasonable. If mature eggs are obtained but fertilisation is unexpectedly low, sperm and fertilisation method deserve review. If fertilised embryos repeatedly arrest, the discussion moves toward embryo biology and laboratory observations. If a transfer occurs but pregnancy does not follow, that is another question again.
Before paying for another cycle, ask the specialist to identify the bottleneck and explain what—if anything—would be changed. “Try again” is not a complete strategy unless the reason is that biological variation itself makes another attempt reasonable and you understand the likely range of outcomes.
ONE CYCLE OR A MULTI-CYCLE PLAN?AFTER STIMULATION AFTER RETRIEVAL AFTER EMBRYO CULTURE BEFORE ANOTHER PAYMENT
Set review points before treatment momentum takes over
Did the ovaries respond as expected?
Compare the actual follicle response with the specialist's prediction. If response was materially poorer, ask whether that changes the prognosis or the value of another retrieval.
What did maturity tell us?
The number of mature eggs can matter more than the headline retrieval number. Ask whether maturity was within the expected range and whether timing or protocol deserves review.
Where did attrition occur?
Fertilisation and blastocyst development provide information that AMH cannot. Ask the embryology team to explain the pattern rather than reducing the cycle to pass or fail.
What changes—and what stays uncertain?
Agree the rationale, likely cost, expected benefit and point at which you would reconsider. This protects both finances and emotional energy.
MISCARRIAGE & EARLY PREGNANCY
A positive pregnancy test is an important milestone, not the final outcome
Miscarriage risk rises with maternal age, much of it related to chromosomal abnormalities in embryos. For that reason, success discussions after 40 should not stop at biochemical pregnancy or even a first positive test. Ask for live-birth data where available and understand what early follow-up the clinic recommends after transfer.
If you become pregnant in Thailand and plan to return home, establish who will arrange repeat hCG testing where indicated, when ultrasound is expected and who receives the results. Confirm the symptoms that require urgent assessment, including significant pain or bleeding. A clear handover is part of fertility treatment, not an administrative afterthought.
PGT-A may reduce the likelihood of transferring an embryo identified as aneuploid, but it does not guarantee implantation or eliminate miscarriage. The specialist should explain both the potential value and the limitations in your specific embryo cohort.
POSITIVE TEST→ appropriate follow-up → ultrasound → handover home
TAKE THIS TO THE CONSULTATION
20 questions for IVF over 40 in Thailand
01What does my age change in your prognosis for me?
02What do my AMH and AFC suggest about expected response?
03What did you learn from my previous IVF cycles?
04What starting stimulation protocol would you use and why?
05What would make you cancel or change the cycle?
06What outcome statistics do you have for my age group?
07Are those figures pregnancy, live birth, per transfer or per cycle started?
08When would you recommend ICSI in my case?
09What is your blastocyst culture approach?
10Would you discuss PGT-A with me, and why?
11What happens if I produce only one blastocyst?
12Would you ever suggest embryo banking over multiple retrievals?
13What is your embryo-transfer policy for my age and embryo status?
14What pre-treatment medical clearance do I need?
15What does the quoted price include and exclude?
16How much should I budget for medication?
17What additional costs arise if embryos are frozen or tested?
18How long should I plan to remain in Thailand?
19What records will I receive before flying home?
20At what point would you recommend we reconsider the strategy?
PLAN THE JOURNEY, NOT JUST THE TREATMENT
Build your Thailand trip around your treatment.
Treatment in Thailand often means several appointments, with free days or recovery time in between. Plan where you stay, how you spend those days and when you fly — then send it to JLIT alongside your treatment enquiry.
- Choose your city and dates around your appointments
- Explore accommodation close to your clinic or hospital
- Free, no-obligation — no booking or payment
HOMERecords + preliminary tests
THAILANDReview + stimulation + retrieval
LABEmbryology + optional testing
NEXT STEPTransfer now/later or reassess
INTERNATIONAL PATIENT PLANNING
Build flexibility into the trip
IVF dates are biological dates. Follicles do not grow according to airline bookings, and retrieval timing can shift. If you travel to Thailand for treatment, build flexibility around monitoring and retrieval rather than arranging a departure that forces the clinic to fit medicine around a ticket.
Ask which tests can be completed at home, when you must physically arrive, how remote monitoring is handled, whether your partner must be present for specific stages, and how long you may need to remain after retrieval or transfer. If embryos are frozen, a later transfer trip may be clinically and practically separate from the retrieval cycle.
RED FLAGSGuaranteed success One overall percentage AMH as destiny Add-ons without a reason
Be cautious when certainty is being sold to you
No clinic can guarantee that an IVF cycle will produce a live birth.
A clinic-wide pregnancy figure without age, denominator and outcome definition is difficult to use.
Reserve markers help predict response; they do not replace age or provide a personal live-birth guarantee.
Ask what problem an additional procedure is intended to solve in your case and what evidence supports it.
ONE CHILD OR A FUTURE FAMILY?
Your goal can change today's IVF strategy
If your aim is one pregnancy now, the decision pathway may differ from someone hoping for two children. Ask how your age and expected embryo numbers affect the possibility of future family building. Where appropriate, the specialist may discuss embryo banking, but that strategy should come with a clear rationale, cost and review point.
This is also where emotional and financial limits matter. Decide in advance what information would make you consider another retrieval, transfer available embryos, seek a second opinion or discuss alternative routes to parenthood. A plan can be hopeful without being open-ended.
FROM RESEARCH TO A WORKABLE PLAN
JLIT can bring the clinical and travel questions into one comparison
For international patients, fertility treatment can become fragmented: one clinic page, a doctor biography, a price screenshot, a hotel search and a separate flight calendar. JLIT's role is to help bring those decisions together around the treatment you are actually considering.
01Tell us your treatment goal and history
02Compare relevant providers and specialists
03Clarify current pricing and inclusions
04Coordinate questions and consultation information
05Plan the treatment trip around the clinical pathway
QUESTIONS PATIENTS COMMONLY ASK
IVF after 40 in Thailand: FAQ
Can I have IVF in Thailand after 40?
Potentially, yes, but suitability is individual. A fertility specialist should assess age, ovarian reserve, medical history, previous treatment, sperm factors and pregnancy health. Individual clinics may also have their own acceptance policies.
Is 40 too old for IVF with my own eggs?
There is no single answer for every patient. The probability of success with own eggs generally declines with age, particularly because embryo chromosomal abnormalities become more common. Your own prognosis requires individual assessment.
Does a good AMH mean I have good-quality eggs?
No. AMH is primarily an ovarian-reserve marker and is useful for estimating response to stimulation. It is not a direct test of egg quality and does not remove the effect of age.
Is ICSI better for women over 40?
ICSI is a fertilisation technique. Whether it is appropriate depends on the sperm and treatment circumstances; age alone does not mean it automatically solves embryo-quality issues.
Should every woman over 40 have PGT-A?
Not automatically. PGT-A may be discussed because aneuploidy increases with age, but usefulness depends on your circumstances and the number of embryos available. Ask what decision the result would change.
How many IVF cycles might I need?
No clinic can know in advance. Some patients achieve a transferable embryo in one retrieval; others require more than one cycle or may not produce a transferable embryo. Ask for realistic stage-by-stage expectations and stopping/review points.
Are IVF success rates after 40 reliable?
They can be useful only when you know the age group, outcome definition, denominator, time period and patient population. Live birth per cycle started tells a different story from pregnancy per selected embryo transfer.
How long should I stay in Thailand for IVF?
It depends on whether preliminary monitoring is performed at home, your stimulation response, retrieval timing and whether transfer occurs in the same trip. Obtain a clinic-specific schedule before booking inflexible travel.
Does IVF after 40 cost more?
It can. Medication requirements, additional testing, embryo freezing, PGT, multiple retrievals or a later frozen transfer can increase total cost. Compare complete written quotations rather than headline package prices.
Can JLIT help me compare fertility treatment?
Yes. JLIT can help organise relevant provider and specialist options, current pricing and treatment questions, and connect those decisions with practical treatment-trip planning.
MAKE THE NEXT DECISION USEFUL
Compare IVF in Thailand around your evidence—not your age alone.
Tell JLIT your age, treatment goal, previous fertility history and the practical dates you are working around. We can help structure a comparison of suitable providers, specialists, current pricing and treatment-trip options so you can ask better questions before committing.
